MCA
TMO icon

Morris Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Morris Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.86M Sell
7,607
-95
-1% -$53.2K 3.64% 6
2022
Q2 		$4.18M Buy
7,702
+129
+2% +$71K 3.73% 5
2022
Q1 		$4.47M Sell
7,573
-189
-2% -$109K 3.47% 6
2021
Q4 		$5.18M Sell
7,762
-32
-0.4% -$20K 3.81% 7
2021
Q3 		$4.45M Sell
7,794
-273
-3% -$150K 3.51% 7
2021
Q2 		$4.07M Sell
8,067
-107
-1% -$50.5K 3.08% 9
2021
Q1 		$3.73M Sell
8,174
-272
-3% -$130K 3.03% 12
2020
Q4 		$3.93M Sell
8,446
-491
-5% -$230K 3.23% 9
2020
Q3 		$3.95M Sell
8,937
-572
-6% -$236K 3.48% 8
2020
Q2 		$3.44M Sell
9,509
-546
-5% -$183K 3.11% 11
2020
Q1 		$2.85M Sell
10,055
-413
-4% -$130K 3.05% 11
2019
Q4 		$3.4M Sell
10,468
-190
-2% -$57.6K 2.85% 12
2019
Q3 		$3.1M Sell
10,658
-1,749
-14% -$501K 2.73% 12
2019
Q2 		$3.64M Sell
12,407
-16,810
-58% -$4.63M 3.04% 12
2019
Q1 		$8M Sell
29,217
-1,391
-5% -$346K 6.26% 1
2018
Q4 		$6.85M Sell
30,608
-980
-3% -$230K 5.84% 1
2018
Q3 		$7.71M Sell
31,588
-368
-1% -$84.7K 5.15% 3
2018
Q2 		$6.62M Sell
31,956
-2,785
-8% -$591K 4.64% 3
2018
Q1 		$7.17M Sell
34,741
-1,133
-3% -$238K 4.75% 2
2017
Q4 		$6.81M Sell
35,874
-906
-2% -$174K 4.45% 2
2017
Q3 		$6.96M Sell
36,780
-645
-2% -$117K 4.65% 2
2017
Q2 		$6.53M Sell
37,425
-2,520
-6% -$423K 4.61% 2
2017
Q1 		$6.14M Sell
39,945
-4,723
-11% -$722K 4.45% 2
2016
Q4 		$6.3M Sell
44,668
-7,292
-14% -$1.08M 4.38% 2
2016
Q3 		$8.27M Sell
51,960
-5,340
-9% -$823K 5.13% 1
2016
Q2 		$8.47M Buy
57,300
+8,482
+17% +$1.25M 5.03% 1
2016
Q1 		$6.91M Buy
48,818
+408
+0.8% +$54.7K 4.68% 1
2015
Q4 		$6.87M Buy
+48,410
New +$6.46M 4.78% 1

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morris Capital Advisors's TMO Position: Q3 2022 in Review

Morris Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q3 2022, selling an estimated $53.2K and leaving 7,607 shares worth $3.86M. The position accounts for 3.64% of the portfolio, ranked #6.

Morris Capital Advisors first reported a position in TMO in Q4 2015 and has held it in 28 quarters since. The position peaked at $8.47M in Q2 2016. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Morris Capital Advisors held 7,607 shares of Thermo Fisher Scientific worth $3.86M as of Q3 2022.
  • Morris Capital Advisors sold 95 Thermo Fisher Scientific shares in Q3 2022, an estimated $53.2K.
  • Thermo Fisher Scientific made up 3.64% of Morris Capital Advisors's portfolio in Q3 2022, its #6 holding.
  • Morris Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 28 quarters since.
  • Morris Capital Advisors's Thermo Fisher Scientific position peaked at $8.47M in Q2 2016.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Morris Capital Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.